Elanco

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Elanco and other ETFs, options, and stocks.

About ELAN

Elanco Animal Health, Inc. develops, manufactures, and markets products for pets and farm animals. Its products include Advantage Family, Atopica, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, TruCan, AviPro, Baytril, Catosal, Denagard, and Experior. 

CEO
Jeffrey N. Simmons
CEOJeffrey N. Simmons
Employees
9,900
Employees9,900
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1954
Founded1954
Employees
9,900
Employees9,900

ELAN Key Statistics

Market cap
11.61B
Market cap11.61B
Price-Earnings ratio
-50.75
Price-Earnings ratio-50.75
Dividend yield
Dividend yield
Average volume
4.35M
Average volume4.35M
High today
$23.65
High today$23.65
Low today
$23.28
Low today$23.28
Open price
$23.57
Open price$23.57
Volume
576.57K
Volume576.57K
52 Week high
$27.72
52 Week high$27.72
52 Week low
$8.02
52 Week low$8.02

Stock Snapshot

Elanco(ELAN) stock is priced at $23.36, giving the company a market capitalization of 11.61B. It carries a P/E multiple of -50.75.

On 2026-03-11, Elanco(ELAN) stock moved within a range of $23.28 to $23.65. With shares now at $23.36, the stock is trading +0.4% above its intraday low and -1.2% below the session's peak.

Trading activity shows a volume of 576.57K, compared to an average daily volume of 4.35M.

Over the past 52 weeks, Elanco(ELAN) stock has traded between a high of $27.72 and a low of $8.02.

Over the past 52 weeks, Elanco(ELAN) stock has traded between a high of $27.72 and a low of $8.02.

ELAN News

Simply Wall St 1d
Why Elanco Is Down 8.2% After Guiding Higher 2026 Revenue Despite Ongoing Net Losses

Elanco Animal Health reported past fourth quarter 2025 sales of US$1,144 million and full-year 2025 sales of US$4,715 million, alongside a net loss of US$276 mi...

Why Elanco Is Down 8.2% After Guiding Higher 2026 Revenue Despite Ongoing Net Losses
Simply Wall St 4d
Is It Time To Reassess Elanco After A 110% One-Year Share Price Surge

If you are wondering whether Elanco Animal Health's current share price lines up with its underlying worth, this article will walk through the key numbers that...

Is It Time To Reassess Elanco After A 110% One-Year Share Price Surge

Analyst ratings

88%

of 17 ratings
Buy
88.2%
Hold
5.9%
Sell
5.9%

People also own

Based on the portfolios of people who own ELAN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.